Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 18 | 17 | 19 | 24 | 46 |
| Income taxes - deferred | -7 | 9 | 3 | N/A | N/A |
| Accounts receivable | -53 | 92 | -192 | -67 | 153 |
| Accounts payable and accrued liabilities | -493 | 147 | -553 | 725 | 344 |
| Other Working Capital | -440 | 618 | -1,531 | 755 | 593 |
| Other Operating Activity | -400 | -1,979 | -822 | -1,455 | -1,420 |
| Operating Cash Flow | $-1,376 | $-1,096 | $-3,077 | $-19 | $-282 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -6 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 49 | -49 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $43 | $-49 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10 | -15 | -16 | -6 | N/A |
| Common Stock Issued | -22 | 2,996 | 6,325 | -78 | -1 |
| Other Financing Activity | 0 | 0 | 0 | -14 | -51 |
| Financing Cash Flow | $-32 | $2,981 | $6,309 | $-98 | $-52 |
| Exchange Rate Effect | 1 | 3 | -4 | -23 | 0 |
| Beginning Cash Position | 5,246 | 3,360 | 131 | 395 | 784 |
| End Cash Position | 3,847 | 5,246 | 3,360 | 129 | 395 |
| Net Cash Flow | $-1,400 | $1,885 | $3,233 | $-74 | $-383 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,376 | -1,096 | -3,077 | -19 | -282 |
| Free Cash Flow | -1,376 | -1,096 | -3,077 | -19 | -282 |